{
    "nctId": "NCT02161315",
    "briefTitle": "Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer",
    "officialTitle": "A Randomized Study of Steroid Aromatase Inhibitors Versus Progestogens for Non-Steroid Aromatase Inhibitor-resistanced Late Stage Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Carcinoma Breast Stage IV",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 80,
    "primaryOutcomeMeasure": "RECIST 1.1",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients must be the postmenopausal women\n2. Patients must be diagnosed with advanced breast cancer by imageology\uff0ccytology or histopathology\n3. Immunohistochemistry shows ER and/or PR positive\n4. Patients ECOG score must be 0-2\n5. Drug resistant about Non-Steroid Aromatase Inhibitors\n\nExclusion Criteria:\n\n1. Not suitable for endocrine therapy\n2. Have receive the standard Steroid Aromatase Inhibitors treatment\n3. Severe hepatic dysfunction",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}